← Back to all trials
Active Not Recruiting
NCT05658120
Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
Conditions: Postperfusion Syndrome
Sex: All
Ages: 18 Years – 80 Years
Enrollment: 246
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Location: Spain
Summary
The incidence of postreperfusion syndrome (PRS) and vasoplegic syndrome (VS) is unknown, and occasionally can be confused since these syndromes share some hemodynamic characteristics.
In these cases, monitoring with Swan Ganz catheter may be useful to make the differential diagnosis.
The main outcome was to determine the incidence and prognosis of patients with PRS and VS
Eligibility Criteria
Inclusion Criteria: Consecutive patients ≥ 18 years-old, who underwent liver transplant surgery, monitored with Swan-Ganz catheter, with norepinephrine/adrenaline support during transplant surgeryExclusion Criteria:Acute liver failure, combined liver/kidney transplantation, re-transplantation, living-donor related transplantation, moderate to severe vascular and valvular heart disease, chronic kidney disease (serum creatinine > 1.5), moderate and sever hepato-pulmonary syndrome, moderate and sever porto-pulmonary syndrome
Source: ClinicalTrials.gov (NCT05658120). StuddyBuddy aggregates publicly available trial information.